世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

APACの遺伝子検査市場 2022-2026


Genetic Testing Market in APAC 2022-2026

APACの遺伝子検査市場 2022-2026 TechnavioはAPACの遺伝子検査市場を監視しており、2022年から2026年の間に13億1000万ドルの成長が見込まれ、予測期間中にCAGR13.21%で進行しています。当レポートでは、APACの遺... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年2月9日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

APACの遺伝子検査市場 2022-2026
TechnavioはAPACの遺伝子検査市場を監視しており、2022年から2026年の間に13億1000万ドルの成長が見込まれ、予測期間中にCAGR13.21%で進行しています。当レポートでは、APACの遺伝子検査市場について、市場規模や予測、トレンド、成長ドライバー、課題などの全体的な分析に加え、約25社のベンダーを網羅したベンダー分析も行っています。
現在の市場シナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、高度な遺伝子検査製品の承認が進み、腫瘍学における遺伝子検査の適用が拡大することによって牽引されています。また、先進的な遺伝子検査製品の承認が進んでいることも、市場の成長を後押しすると予想されます。
APACの遺伝子検査市場の分析には、製品およびアプリケーションのセグメントが含まれます。
TechnavioのAPACの遺伝子検査市場は、以下のようにセグメント化されています。
- 製品別
- 機器
- 消耗品
- アプリケーション別
- がん診断
- 遺伝子疾患診断
- 循環器疾患診断
- その他
本調査では、今後数年間におけるAPACの遺伝子検査市場の成長を促進する主要な理由の1つとして、戦略的パートナーシップの高まりを挙げています。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な図を提示します。APACの遺伝子検査市場に関する弊社のレポートは、以下の分野を対象としています。
- 遺伝子検査市場のサイジング
- 遺伝子検査市場予測
- 遺伝子検査市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., Mapmygenome India Ltd., Myriad Genetics Inc., QIAGEN NV, Thermo Fisher Scientific Inc.また、APACの遺伝子検査市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/genetic-testing-market-industry-in-apac-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Equipment - Market size and forecast 2021-2026
o Consumables - Market size and forecast 2021-2026
o Market opportunity by Product
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Cancer diagnosis - Market size and forecast 2021-2026
o Genetic disease diagnosis - Market size and forecast 2021-2026
o Cardiovascular disease diagnosis - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
o Overview
• Drivers, Challenges, and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor Disruption
o Competitive Scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Bio Rad Laboratories Inc.
o Danaher Corp.
o Exact Sciences Corp.
o F. Hoffmann-La Roche Ltd.
o Illumina Inc.
o Mapmygenome India Ltd.
o Myriad Genetics Inc.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research Methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Product - Market share 2021-2026 (%)
• 22: Comparison by Product
• 23: Equipment - Market size and forecast 2021-2026 ($ million)
• 24: Equipment - Year-over-year growth 2021-2026 (%)
• 25: Consumables - Market size and forecast 2021-2026 ($ million)
• 26: Consumables - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Product
• 28: Application - Market share 2021-2026 (%)
• 29: Comparison by Application
• 30: Cancer diagnosis - Market size and forecast 2021-2026 ($ million)
• 31: Cancer diagnosis - Year-over-year growth 2021-2026 (%)
• 32: Genetic disease diagnosis - Market size and forecast 2021-2026 ($ million)
• 33: Genetic disease diagnosis - Year-over-year growth 2021-2026 (%)
• 34: Cardiovascular disease diagnosis - Market size and forecast 2021-2026 ($ million)
• 35: Cardiovascular disease diagnosis - Year-over-year growth 2021-2026 (%)
• 36: Others - Market size and forecast 2021-2026 ($ million)
• 37: Others - Year-over-year growth 2021-2026 (%)
• 38: Market opportunity by Application
• 39: Customer landscape
• 40: Impact of drivers and challenges
• 41: Vendor landscape
• 42: Landscape disruption
• 43: Industry risks
• 44: Vendors covered
• 45: Market positioning of vendors
• 46: Abbott Laboratories - Overview
• 47: Abbott Laboratories - Business segments
• 48: Abbott Laboratories - Key offerings
• 49: Abbott Laboratories - Key customers
• 50: Abbott Laboratories - Segment focus
• 51: Bio Rad Laboratories Inc. - Overview
• 52: Bio Rad Laboratories Inc. - Business segments
• 53: Bio Rad Laboratories Inc. - Key offerings
• 54: Bio Rad Laboratories Inc. - Key customers
• 55: Bio Rad Laboratories Inc. - Segment focus
• 56: Danaher Corp. - Overview
• 57: Danaher Corp. - Business segments
• 58: Danaher Corp. - Key offerings
• 59: Danaher Corp. - Key customers
• 60: Danaher Corp. - Segment focus
• 61: Exact Sciences Corp. - Overview
• 62: Exact Sciences Corp. - Business segments
• 63: Exact Sciences Corp. - Key offerings
• 64: Exact Sciences Corp. - Key customers
• 65: Exact Sciences Corp. - Segment focus
• 66: F. Hoffmann-La Roche Ltd. - Overview
• 67: F. Hoffmann-La Roche Ltd. - Business segments
• 68: F. Hoffmann-La Roche Ltd. - Key offerings
• 69: F. Hoffmann-La Roche Ltd. - Key customers
• 70: F. Hoffmann-La Roche Ltd. - Segment focus
• 71: Illumina Inc. - Overview
• 72: Illumina Inc. - Product and service
• 73: Illumina Inc. - Key offerings
• 74: Illumina Inc. - Key customers
• 75: Illumina Inc. - Segment focus
• 76: Mapmygenome India Ltd. - Overview
• 77: Mapmygenome India Ltd. - Product and service
• 78: Mapmygenome India Ltd. - Key offerings
• 79: Mapmygenome India Ltd. - Key customers
• 80: Mapmygenome India Ltd. - Segment focus
• 81: Myriad Genetics Inc. - Overview
• 82: Myriad Genetics Inc. - Business segments
• 83: Myriad Genetics Inc. - Key offerings
• 84: Myriad Genetics Inc. - Key customers
• 85: Myriad Genetics Inc. - Segment focus
• 86: QIAGEN NV - Overview
• 87: QIAGEN NV - Business segments
• 88: QIAGEN NV - Key offerings
• 89: QIAGEN NV - Key customers
• 90: QIAGEN NV - Segment focus
• 91: Thermo Fisher Scientific Inc. - Overview
• 92: Thermo Fisher Scientific Inc. - Business segments
• 93: Thermo Fisher Scientific Inc. - Key offerings
• 94: Thermo Fisher Scientific Inc. - Key customers
• 95: Thermo Fisher Scientific Inc. - Segment focus
• 96: Currency conversion rates for US$
• 97: Research Methodology
• 98: Validation techniques employed for market sizing
• 99: Information sources
• 100: List of abbreviations

 

ページTOPに戻る


 

Summary

Genetic Testing Market in APAC 2022-2026
Technavio has been monitoring the genetic testing market in APAC and it is poised to grow by $ 1.31 bn during 2022-2026, progressing at a CAGR of 13.21% during the forecast period. Our report on the genetic testing market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising approval of advanced genetic testing products and increasing application of genetic testing in oncology. In addition, rising approval of advanced genetic testing products is anticipated to boost the growth of the market as well.
The genetic testing market in APAC analysis includes product and application segments.
Technavio's genetic testing market in APAC is segmented as below:
• By Product
• Equipment
• Consumables
• By Application
• Cancer diagnosis
• Genetic disease diagnosis
• Cardiovascular disease diagnosis
• Others
This study identifies the rising strategic partnershipas one of the prime reasons driving the genetic testing market growth in APAC during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on genetic testing market in APAC covers the following areas:
• Genetic testing market sizing
• Genetic testing market forecast
• Genetic testing market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genetic testing market vendors in APAC that include Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., Mapmygenome India Ltd., Myriad Genetics Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the genetic testing market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/genetic-testing-market-industry-in-apac-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Equipment - Market size and forecast 2021-2026
o Consumables - Market size and forecast 2021-2026
o Market opportunity by Product
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Cancer diagnosis - Market size and forecast 2021-2026
o Genetic disease diagnosis - Market size and forecast 2021-2026
o Cardiovascular disease diagnosis - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
o Overview
• Drivers, Challenges, and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor Disruption
o Competitive Scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Bio Rad Laboratories Inc.
o Danaher Corp.
o Exact Sciences Corp.
o F. Hoffmann-La Roche Ltd.
o Illumina Inc.
o Mapmygenome India Ltd.
o Myriad Genetics Inc.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research Methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Product - Market share 2021-2026 (%)
• 22: Comparison by Product
• 23: Equipment - Market size and forecast 2021-2026 ($ million)
• 24: Equipment - Year-over-year growth 2021-2026 (%)
• 25: Consumables - Market size and forecast 2021-2026 ($ million)
• 26: Consumables - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Product
• 28: Application - Market share 2021-2026 (%)
• 29: Comparison by Application
• 30: Cancer diagnosis - Market size and forecast 2021-2026 ($ million)
• 31: Cancer diagnosis - Year-over-year growth 2021-2026 (%)
• 32: Genetic disease diagnosis - Market size and forecast 2021-2026 ($ million)
• 33: Genetic disease diagnosis - Year-over-year growth 2021-2026 (%)
• 34: Cardiovascular disease diagnosis - Market size and forecast 2021-2026 ($ million)
• 35: Cardiovascular disease diagnosis - Year-over-year growth 2021-2026 (%)
• 36: Others - Market size and forecast 2021-2026 ($ million)
• 37: Others - Year-over-year growth 2021-2026 (%)
• 38: Market opportunity by Application
• 39: Customer landscape
• 40: Impact of drivers and challenges
• 41: Vendor landscape
• 42: Landscape disruption
• 43: Industry risks
• 44: Vendors covered
• 45: Market positioning of vendors
• 46: Abbott Laboratories - Overview
• 47: Abbott Laboratories - Business segments
• 48: Abbott Laboratories - Key offerings
• 49: Abbott Laboratories - Key customers
• 50: Abbott Laboratories - Segment focus
• 51: Bio Rad Laboratories Inc. - Overview
• 52: Bio Rad Laboratories Inc. - Business segments
• 53: Bio Rad Laboratories Inc. - Key offerings
• 54: Bio Rad Laboratories Inc. - Key customers
• 55: Bio Rad Laboratories Inc. - Segment focus
• 56: Danaher Corp. - Overview
• 57: Danaher Corp. - Business segments
• 58: Danaher Corp. - Key offerings
• 59: Danaher Corp. - Key customers
• 60: Danaher Corp. - Segment focus
• 61: Exact Sciences Corp. - Overview
• 62: Exact Sciences Corp. - Business segments
• 63: Exact Sciences Corp. - Key offerings
• 64: Exact Sciences Corp. - Key customers
• 65: Exact Sciences Corp. - Segment focus
• 66: F. Hoffmann-La Roche Ltd. - Overview
• 67: F. Hoffmann-La Roche Ltd. - Business segments
• 68: F. Hoffmann-La Roche Ltd. - Key offerings
• 69: F. Hoffmann-La Roche Ltd. - Key customers
• 70: F. Hoffmann-La Roche Ltd. - Segment focus
• 71: Illumina Inc. - Overview
• 72: Illumina Inc. - Product and service
• 73: Illumina Inc. - Key offerings
• 74: Illumina Inc. - Key customers
• 75: Illumina Inc. - Segment focus
• 76: Mapmygenome India Ltd. - Overview
• 77: Mapmygenome India Ltd. - Product and service
• 78: Mapmygenome India Ltd. - Key offerings
• 79: Mapmygenome India Ltd. - Key customers
• 80: Mapmygenome India Ltd. - Segment focus
• 81: Myriad Genetics Inc. - Overview
• 82: Myriad Genetics Inc. - Business segments
• 83: Myriad Genetics Inc. - Key offerings
• 84: Myriad Genetics Inc. - Key customers
• 85: Myriad Genetics Inc. - Segment focus
• 86: QIAGEN NV - Overview
• 87: QIAGEN NV - Business segments
• 88: QIAGEN NV - Key offerings
• 89: QIAGEN NV - Key customers
• 90: QIAGEN NV - Segment focus
• 91: Thermo Fisher Scientific Inc. - Overview
• 92: Thermo Fisher Scientific Inc. - Business segments
• 93: Thermo Fisher Scientific Inc. - Key offerings
• 94: Thermo Fisher Scientific Inc. - Key customers
• 95: Thermo Fisher Scientific Inc. - Segment focus
• 96: Currency conversion rates for US$
• 97: Research Methodology
• 98: Validation techniques employed for market sizing
• 99: Information sources
• 100: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る